We have previously demonstrated that the combined inhibition of MEK and PD-L1 in NSCLC patients derived three dimensional cultures exerted significant synergistic effect in terms of immune-dependent cancer cell death. The gene discussed is MAP2K7; the disease is non-small cell lung carcinoma.